Abnormal Splicing of GALC Transcripts Underlies Unusual Cases of Krabbe Disease
<b>Background/Objectives</b>: Krabbe disease (KD) is a hereditary lysosomal disorder whose hallmark is progressive demyelination, with variable involvement of the central nervous system. It is caused by pathogenic variants in the <i>GALC</i> gene that disrupt the function of its gene product, the lysosomal enzyme galactosylceramidase. We analyzed two unrelated cases (one early infantile and one adult) with a clinical suspicion of KD. <b>Methods</b>: We used a combination of biochemical techniques (high-performance liquid chromatography-tandem mass spectrometry), NGS (resequencing gene panels), splicing assays, and molecular modeling to identify and analyze the pathogenicity of the variants underlying the disorder. <b>Results</b>: The two probands were compound heterozygotes for disease-causing variants in the <i>GALC</i> gene, encoding the lysosomal hydrolase galactosylceramidase. Three of the variants were novel and caused aberrant splicing, either by exon skipping (c.908+5G>A and c.1034-1G>C) or by inclusion of a cryptic, deep intronic pseudoexon (c.621+772G>C). The fourth variant was a known missense change (c.956A>G, p.(Tyr319Cys)) with conflicting interpretations of pathogenicity in the databases. <b>Conclusions</b>: We demonstrated the pathogenicity of the three novel splicing variants, all with strong impact on galactosylceramidase function. We also concluded that the c.956A>G missense variant is a hypomorph usually underlying the later-onset, milder phenotypes of KD. Our results stress the importance of integrated approaches combining clinical, biochemical, and genetic testing to obtain a definitive diagnosis of lysosomal diseases.
Authors
- Cristobal Colón (ORCID: https://orcid.org/0000-0002-9711-2812)
- María Domínguez-Ruiz (ORCID: https://orcid.org/0000-0002-7583-0370)
- Val F. Lanza (ORCID: https://orcid.org/0000-0003-0870-9500)
- Pablo Crujeiras (ORCID: https://orcid.org/0000-0002-1320-6150)
- Laura López‐Marín (ORCID: https://orcid.org/0000-0002-0251-5812)
- Juan Luis Chico‐García (ORCID: https://orcid.org/0000-0001-6557-912X)
- Amaya Bélanger-Quintana (ORCID: https://orcid.org/0000-0003-0102-8956)
- María del Mar Meijón-Ortigueira (ORCID: https://orcid.org/0000-0002-2644-342X)
- Jesús Villarrubia (ORCID: https://orcid.org/0000-0003-4501-5938)
- Sinziana Stanescu (ORCID: https://orcid.org/0000-0003-0340-4580)
- Rosana Torremocha
- Daniel Rodrigues (ORCID: https://orcid.org/0000-0002-2934-1699)
- Francisco Castillo (ORCID: https://orcid.org/0000-0003-0467-4320)
- Patricia Muñoz-Díez
- María-Elena de las Heras-Alonso
Institutions
- Universidad de Alcalá (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Hospital Infantil Universitario Niño Jesús (ES)
- Fundación A LA PAR (ES)
- Centro de Investigación Biomédica en Red (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Instituto de Investigación Sanitaria de Santiago (ES)
- Hospital Universitario Ramón y Cajal (ES)
Publication Details
- Journal
- Biomedicines
- Published
- 2025-12-17
- DOI
- https://doi.org/10.3390/biomedicines13123114
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi